KYNETIC

KYNETIC Logo

                                                                        Follow KYNETIC on Twitter

The KYNETIC (Kentucky Network for Innovation & Commercialization) program supports faculty, staff, trainees, and students who want to accelerate the introduction of their groundbreaking innovations to the marketplace to address unmet needs to benefit human health. 

KYNETIC does this by:

  • Developing infrastructure for identifying technologies
  • Allocating funding (up to $200k/technology) for product definition studies (e.g., feasibility studies, prototype development, or proof-of-concept studies)
  • Providing access to early-stage development expertise and mentorship
  • Offering hands-on skills development in entrepreneurism
  • Accelerating development of commercialization strategies

Eligible KYNETIC technologies must originate from a participating University or community/technical college in Kentucky and focus on healthcare-related products. 

The KYNETIC program is funded through the National Institute of Health’s Research Evaluation and Commercialization Hub (REACH) program. The goal of the program is to support proof-of-concept centers (hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.

The KYNETIC hub is led by the University of Kentucky (UK), University of Louisville (UofL) and the Kentucky Cabinet for Economic Development (KY CED), with support from the Kentucky Commercialization Ventures (KCV) program. The long-term goals of the program are to foster commercialization success, economic development and entrepreneurial culture change throughout Kentucky.

Pre-Application due February 15, 2021.

Pre-Application Materials:

Email pre-application materials to kynetic@uky.edu


KYNETIC LOCAL ECOSYSTEM

KYNETIC Local Ecosystem (see PDF for details)

                                                                  KYNETIC Local Ecosystem (pdf with links, 1 pg)

KYNETIC CYCLE 2 PROJECTS

Project Title

PI Last Name

Institution

Novel compounds for diagnosing, treating, and monitoring triple negative breast cancer

Calderon

Eastern Kentucky University

A novel anti-IL-6 inhibitor as a new immunotherapeutic for uveitis

Donninger

University of Louisville

A novel therapeutic target for hepatic lipid accumulation

Gordon

University of Kentucky

Power driven bone biopsy trephine needle system

Larkin

University of Kentucky

Rapid Trocar Site Closure Device

Metzinger

University of Louisville

Development of a differential scanning calorimetry system for rapid identification and differentiation of specific causes of heart damage and myocardial infarction

Roussel

University of Louisville

A highly selective mPGES-1 inhibitor as an effective and non-addictive analgesic

Zheng

University of Kentucky

KYNETIC CYCLE 1 PROJECTS

Project Title

PI Last Name

Institution

Novel enzyme therapeutics targeting Alzheimer’s disease

Bruntz

University of Kentucky

A novel anti-IL-6 inhibitor as a new immunotherapeutic for uveitis

Donninger

University of Louisville

A novel therapeutic target for hepatic lipid accumulation

Gordon

University of Kentucky

Power driven bone biopsy trephine needle system

Larkin

University of Kentucky

Development of a differential scanning calorimetry system for rapid identification and differentiation of specific causes of heart damage and myocardial infarction

Roussel

University of Louisville

Liposomal azithromycin to reduce cardiac inflammation

Venditto

University of Kentucky

A highly selective mPGES-1 inhibitor as an effective and non-addictive analgesic

Zheng

University of Kentucky

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs)

Why is KYNETIC different from other grant programs?

The KYNETIC program is not a traditional grant program; it is product-focused, milestone-driven and requires business-case project management. Applicants who are invited to submit a full application will work with KYNETIC staff and/or mentors to develop a product development plan and timeline with specified milestones.

What benchmarks will I have to meet in the program?

Receipt of funding for selected projects will be milestone-driven and KYNETIC staff will monitor development progress. There will be a continuation evaluation (go/no-go decision) every six months and non-progressing projects may be terminated and replaced with new projects.

Who is eligible for the KYNETIC program?

This RFA is open to all faculty, staff, trainees, and students at participating Kentucky state universities and community colleges. Non-faculty applicants must identify a faculty member who is willing to sponsor their application. Applications must focus on developing products that have the potential to improve patient care or enhance human health.

All types of products (e.g. therapeutic, preventative, device, test, software) are eligible. Having multiple Principal Investigators (up to three) is optional but permitted.

Does my institution participate in the KYNETIC program?

The following institutions participate in the KYNETIC network:

University of Kentucky, University of Louisville, Eastern Kentucky University, Kentucky State University, Morehead State University, Murray State University, Northern Kentucky University, and Western Kentucky University. The network also includes the 16 colleges in the Kentucky Community and Technical College System.

Does my product have to treat one specific disease?

There is no disease-specific requirement, but it must be related to human health.

What’s the policy on intellectual property?

Applications should involve ideas that originate from within a participating institution (making them potentially eligible for patent protection or some other mechanism that will return income to the program) or university-derived technologies with pending/issued patents or copyright. Technologies that are already licensed to a company are not eligible.

What’s the budget?

Requests for up to $50,000 per project, over a period of 6 months, will be considered. Projects are eligible for competitive renewal every 6 months until a maximum of $200,000 per technology is reached.